Categories: News

Cango Inc. Announces August 2025 Bitcoin Production and Mining Operations Update

HONG KONG, Sept. 2, 2025 /PRNewswire/ — Cango Inc. (NYSE: CANG) (“Cango” or the “Company”) today published its Bitcoin production and mining operations update for August 2025.

- Advertisement -

Bitcoin Mining Production and Mining Operations Update for August 2025

- Advertisement -

Metric

August 2025 1

July 2025 1

Number of Bitcoin produced

663.7

650.5

Average number of Bitcoin produced per day

21.41

20.99

Total number of Bitcoin held 2

5,193.4

4,529.7

Deployed hashrate

50 EH/s

50 EH/s

Average operating hashrate 3

43.74 EH/s

 40.91 EH/s

1.      Unaudited, estimated.

2.      As of month-end.

3.      Average over the month.

Note: Cango holds Bitcoin for the long term and does not currently intend to sell any of its Bitcoin holdings.

Paul Yu, CEO and Director of Cango, commented, “With our new 50 EH/s deployed capacity now fully operational since July, our average operating hashrate has increased by 6.9% month-over-month. We are also pleased to share that we mined 663.7 Bitcoins this month, propelling our Bitcoin treasury past the 5,000 milestone. This achievement powerfully validates our strategy and strengthens our foundation for sustainable growth. Meanwhile, we have continued ramping up our core mining operations through targeted initiatives to boost fleet efficiency. This includes diligent maintenance of our existing fleet to ensure consistent operations, selective upgrading of older miners to next-generation models, and our recent acquisition of a 50 MW Bitcoin mining facility in the US state of Georgia. Looking ahead, we see significant potential to further optimize our operating efficiency and capture emerging opportunities in the energy and HPC sectors.”

- Advertisement -

About Cango Inc.

- Advertisement -

Cango Inc. (NYSE: CANG) is primarily engaged in the Bitcoin mining business, with operations strategically deployed across North America, the Middle East, South America, and East Africa. The Company entered the crypto asset space in November 2024, driven by advancements in blockchain technology, the growing adoption of digital assets, and its commitment to diversifying its business portfolio. In parallel, Cango continues to operate an online international used car export business through AutoCango.com, making it easier for global customers to access high-quality vehicle inventory from China. For more information, please visit: www.cangoonline.com.

- Advertisement -

Investor Relations Contact

- Advertisement -

Juliet YE, Head of Communications
Cango Inc.
Email: ir@cangoonline.com

- Advertisement -

Christensen Advisory
Tel: +852 2117 0861
Email: cango@christensencomms.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2675436/5486546/CANG_LOGO_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cango-inc-announces-august-2025-bitcoin-production-and-mining-operations-update-302543701.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

2 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

2 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

2 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

2 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

2 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

2 hours ago